Cite

HARVARD Citation

    Wada-Shimosato, Y. et al. (2019). Intraventricular Rituximab in Pediatric CD20-positive Refractory Primary Central Nervous System Lymphoma. Journal of pediatric hematology/oncology. 41 (7), p. . [Online]. 
  
Back to record